This is a regulatory disclosure submitted to The Bombay Stock Exchange Limited and The Calcutta Stock Exchange Ltd.
The Board of Directors of Sunil Healthcare Limited is scheduled to meet on Thursday, August 13, 2026. The meeting will be held through video conferencing/audio visual connection. The deemed venue for the meeting is the company's Registered Office at 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049.
The primary agenda for the board meeting is to consider, approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30, 2026.
Furthermore, the company reiterates that the Trading Window for dealing in the company's securities, under the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, is closed. The closure period is from July 01, 2026, till August 15, 2026 (both days inclusive). This closure was previously intimated to the exchanges via a letter dated June 26, 2026.